Annual Operating Profit
-$182.91 M
-$6.41 M-3.63%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual operating income is -$182.91 million, with the most recent change of -$6.41 million (-3.63%) on December 31, 2023.
- During the last 3 years, AXSM annual operating profit has fallen by -$83.82 million (-84.59%).
- AXSM annual operating profit is now -9843.84% below its all-time high of -$1.84 million, reached on December 31, 2013.
Performance
AXSM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$46.23 M
+$29.65 M+39.08%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly operating income is -$46.23 million, with the most recent change of +$29.65 million (+39.08%) on September 30, 2024.
- Over the past year, AXSM quarterly operating profit has increased by +$8.83 million (+16.04%).
- AXSM quarterly operating profit is now -2624.88% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$245.87 M
+$16.07 M+6.13%
September 30, 2024
Summary
- As of February 7, 2025, AXSM TTM operating income is -$245.87 million, with the most recent change of +$16.07 million (+6.13%) on September 30, 2024.
- Over the past year, AXSM TTM operating profit has dropped by -$62.97 million (-34.43%).
- AXSM TTM operating profit is now -14391.25% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AXSM Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.6% | +16.0% | -34.4% |
| 3 y3 years | -84.6% | -38.4% | -105.3% |
| 5 y5 years | -460.6% | -145.8% | -266.4% |
AXSM Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.7% | at low | -607.4% | +39.1% | -97.2% | +6.1% |
| 5 y | 5-year | -172.6% | at low | -607.4% | +39.1% | -266.4% | +6.1% |
| alltime | all time | -9843.8% | at low | -2624.9% | +39.1% | <-9999.0% | +6.1% |
Axsome Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$46.23 M(-39.1%) | -$245.87 M(-6.1%) |
| Jun 2024 | - | -$75.89 M(+10.5%) | -$261.94 M(+6.9%) |
| Mar 2024 | - | -$68.69 M(+24.7%) | -$245.06 M(+34.0%) |
| Dec 2023 | -$182.91 M(+3.6%) | -$55.07 M(-11.6%) | -$182.91 M(-0.4%) |
| Sep 2023 | - | -$62.30 M(+5.6%) | -$183.56 M(+12.1%) |
| Jun 2023 | - | -$59.00 M(+802.8%) | -$163.71 M(+13.1%) |
| Mar 2023 | - | -$6.54 M(-88.3%) | -$144.75 M(-18.0%) |
| Dec 2022 | -$176.50 M(+41.5%) | -$55.72 M(+31.2%) | -$176.50 M(+15.1%) |
| Sep 2022 | - | -$42.45 M(+6.0%) | -$153.39 M(+6.3%) |
| Jun 2022 | - | -$40.04 M(+4.6%) | -$144.35 M(+6.8%) |
| Mar 2022 | - | -$38.29 M(+17.4%) | -$135.15 M(+8.4%) |
| Dec 2021 | -$124.71 M(+25.9%) | -$32.61 M(-2.4%) | -$124.71 M(+4.1%) |
| Sep 2021 | - | -$33.41 M(+8.3%) | -$119.79 M(+11.4%) |
| Jun 2021 | - | -$30.85 M(+10.8%) | -$107.51 M(+13.8%) |
| Mar 2021 | - | -$27.84 M(+0.6%) | -$94.44 M(-4.7%) |
| Dec 2020 | -$99.09 M(+47.7%) | -$27.69 M(+31.1%) | -$99.09 M(+3.4%) |
| Sep 2020 | - | -$21.13 M(+18.8%) | -$95.83 M(+2.5%) |
| Jun 2020 | - | -$17.78 M(-45.3%) | -$93.51 M(+4.9%) |
| Mar 2020 | - | -$32.49 M(+33.0%) | -$89.18 M(+32.9%) |
| Dec 2019 | -$67.11 M | -$24.43 M(+29.9%) | -$67.11 M(+28.7%) |
| Sep 2019 | - | -$18.81 M(+39.9%) | -$52.13 M(+26.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$13.45 M(+29.0%) | -$41.35 M(+15.2%) |
| Mar 2019 | - | -$10.42 M(+10.3%) | -$35.89 M(+10.0%) |
| Dec 2018 | -$32.63 M(+21.0%) | -$9.45 M(+17.7%) | -$32.63 M(+10.1%) |
| Sep 2018 | - | -$8.03 M(+0.5%) | -$29.62 M(+7.0%) |
| Jun 2018 | - | -$7.99 M(+11.5%) | -$27.69 M(+4.7%) |
| Mar 2018 | - | -$7.16 M(+11.2%) | -$26.45 M(-1.9%) |
| Dec 2017 | -$26.96 M(-0.4%) | -$6.44 M(+5.8%) | -$26.96 M(-2.6%) |
| Sep 2017 | - | -$6.09 M(-9.8%) | -$27.66 M(-3.9%) |
| Jun 2017 | - | -$6.75 M(-12.0%) | -$28.78 M(-0.3%) |
| Mar 2017 | - | -$7.67 M(+7.3%) | -$28.86 M(+6.6%) |
| Dec 2016 | -$27.07 M(+194.3%) | -$7.15 M(-0.8%) | -$27.07 M(+17.3%) |
| Sep 2016 | - | -$7.21 M(+5.6%) | -$23.07 M(+29.0%) |
| Jun 2016 | - | -$6.83 M(+16.1%) | -$17.89 M(+36.1%) |
| Mar 2016 | - | -$5.88 M(+86.5%) | -$13.15 M(+43.0%) |
| Dec 2015 | -$9.20 M(+67.6%) | -$3.15 M(+55.9%) | -$9.20 M(+15.1%) |
| Sep 2015 | - | -$2.02 M(-2.9%) | -$7.99 M(+4.3%) |
| Jun 2015 | - | -$2.08 M(+7.8%) | -$7.66 M(+37.4%) |
| Mar 2015 | - | -$1.93 M(-0.8%) | -$5.58 M(+53.0%) |
| Dec 2014 | -$5.49 M(+198.4%) | -$1.95 M(+14.8%) | -$3.65 M(+114.8%) |
| Sep 2014 | - | -$1.70 M | -$1.70 M |
| Dec 2013 | -$1.84 M | - | - |
FAQ
- What is Axsome Therapeutics annual operating income?
- What is the all time high annual operating profit for Axsome Therapeutics?
- What is Axsome Therapeutics annual operating profit year-on-year change?
- What is Axsome Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly operating profit year-on-year change?
- What is Axsome Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Axsome Therapeutics?
- What is Axsome Therapeutics TTM operating profit year-on-year change?
What is Axsome Therapeutics annual operating income?
The current annual operating profit of AXSM is -$182.91 M
What is the all time high annual operating profit for Axsome Therapeutics?
Axsome Therapeutics all-time high annual operating income is -$1.84 M
What is Axsome Therapeutics annual operating profit year-on-year change?
Over the past year, AXSM annual operating income has changed by -$6.41 M (-3.63%)
What is Axsome Therapeutics quarterly operating income?
The current quarterly operating profit of AXSM is -$46.23 M
What is the all time high quarterly operating profit for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly operating income is -$1.70 M
What is Axsome Therapeutics quarterly operating profit year-on-year change?
Over the past year, AXSM quarterly operating income has changed by +$8.83 M (+16.04%)
What is Axsome Therapeutics TTM operating income?
The current TTM operating profit of AXSM is -$245.87 M
What is the all time high TTM operating profit for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM operating income is -$1.70 M
What is Axsome Therapeutics TTM operating profit year-on-year change?
Over the past year, AXSM TTM operating income has changed by -$62.97 M (-34.43%)